Gemita 1400 mg Injection (Gemcitabine)
| Active Ingredient | Gemcitabine |
|---|---|
| Manufacturer: | Fresenius Kabi India Pvt.Ltd. |
| Indication: | Ovarian cancer, Head and neck cancer, Cervical cancer |
| Strength | 1400mg |
| Packaging | 1 Injection in 1 vial |
| Delivery Time | 6 To 15 days |
Gemita 1400 mg Injection contains Gemcitabine, a powerful chemotherapy drug used in the treatment of several types of cancer, including non-small cell lung cancer (NSCLC), pancreatic cancer, bladder cancer, and breast cancer. It belongs to the antimetabolite class, which targets rapidly dividing cancer cells by interrupting DNA synthesis and halting tumor progression.
This high-dose 1400 mg formulation is designed for use in cases requiring an intensive chemotherapy regimen. Administered intravenously (IV) by trained medical professionals, Gemita may be used alone or in combination with other chemotherapy drugs based on the cancer type and treatment stage.








There are no reviews yet.